45 CFR § 180 compliance
C · 70
This hospital published part of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
○Discounted cash price
●Payer-specific negotiated rates
●Min / max negotiated charges
●Free, public, no login required
Procedures listed
23,144
Insurances with rates
11
CPT / HCPCS codes
13,365
Source MRF
Most expensive procedures (gross)
55566105000
$181,686
nadofaragene firadenovec-vncg 3x10exp11 vp/mL suspension 1 each Vial
Gross
$302,809
55566105001
$181,686
nadofaragene firadenovec-vncg 3x10exp11 vp/mL suspension 4 each Vial
Gross
$302,809
71336100101
$120,262
givosiran 189 mg/mL solution 1 mL Vial
Gross
$200,436
74106901
$85,864
risankizumab-rzaa 360 mg/2.4 mL (150 mg/mL) wearable injector 2.4 mL Cartridge
Gross
$143,107
74107001
$85,864
risankizumab-rzaa 360 mg/2.4 mL (150 mg/mL) wearable injector 2.4 mL Cartridge
Gross
$143,107
50242055401
$80,594
ocrelizumab-hyaluronidase-ocsq 920 mg-23000 unit/23 mL solution 23 mL Vial
Gross
$134,323
310453530
$76,139
tremelimumab-actl 20 mg/mL solution 15 mL Vial
Gross
$126,898
69488000301
$73,206
lutetium Lu 177 dotatate 10 mCi/mL (370 MBq/mL) solution 200 millicurie
Gross
$122,010
58468020001
$72,898
alemtuzumab 12 mg/1.2 mL solution 1.2 mL Vial
Gross
$121,497
96009029
$72,824
Pbb Inj, Adstiladrin, per Tx Dos
Gross
$121,374
30237890006
$63,925
sipuleucel-T-lactated ringers 50 million cell/250 mL suspension 250 mL Bag
Gross
$106,542
74725010064
$61,992
kit prep of Ga-68-gozetotide 25 mcg recon soln 50 millicurie Vial
Gross
$103,320
69488001061
$59,613
lutetium Lu-177 vipivotide tetraxetan 27 mCi/mL (1000 MBq/mL) solution 200 millicurie Vial
Gross
$99,356
78121761
$59,613
lutetium Lu-177 vipivotide tetraxetan 27 mCi/mL (1000 MBq/mL) solution 200 millicurie Vial
Gross
$99,356
57894006103
$57,516
ustekinumab 90 mg/mL syringe 1 mL Syringe
Gross
$95,861
50242015001
$56,211
ocrelizumab 30 mg/mL solution 10 mL Vial
Gross
$93,684
78073461
$50,758
canakinumab (PF) 150 mg/mL solution 1 mL Vial
Gross
$84,596
75987008010
$50,662
pegloticase 8 mg/mL solution 1 mL Vial
Gross
$84,436
73475310203
$47,221
efgartigimod-hyaluronidase-qvfc 1008 mg-11200 unit/5.6 mL solution 5.6 mL Vial
Gross
$78,702
72493010303
$46,855
mitoMYcin 40 mg x 2 kit 1 each KIT
Gross
$78,091
79952011001
$46,406
loncastuximab tesirine-lpyl 10 mg recon soln 1 each Vial
Gross
$77,343
75987013015
$46,319
teprotumumab-trbw 500 mg recon soln 1 each Vial
Gross
$77,198
25682002801
$45,842
ravulizumab-cwvz 100 mg/mL solution 11 mL Vial
Gross
$76,403
57894064001
$41,974
guselkumab 100 mg/mL syringe 1 mL Syringe
Gross
$69,956
57894065001
$41,533
guselkumab 200 mg/20 mL (10 mg/mL) solution 20 mL Vial
Gross
$69,221
57894065002
$41,533
guselkumab 200 mg/20 mL (10 mg/mL) solution 20 mL Vial
Gross
$69,221
24582411
$41,522
cabazitaxel 10 mg/mL (first dilution) solution 6 mL Vial
Gross
$69,203
72893000501
$40,641
PRALAtrexate 40 mg/2 mL (20 mg/mL) solution 2 mL Vial
Gross
$67,735
54482030101
$40,318
pegaspargase 750 unit/mL solution 5 mL Vial
Gross
$67,197
944381001
$40,318
pegaspargase 750 unit/mL solution 5 mL Vial
Gross
$67,197
80446040101
$39,553
tebentafusp-tebn 100 mcg/0.5 mL solution 0.5 mL Vial
Gross
$65,922
50242024501
$38,042
pertuzumab-trastuzumab-hy-zzxf 1200 mg-600mg- 30000 unit/15mL solution 15 mL Vial
Gross
$63,404
74347303
$37,215
leuprolide acetate (6 month) 45 mg syringe kit 1 each KIT
Gross
$62,025
59572077501
$34,811
luspatercept-aamt 50 mg/mL recon soln 1.5 mL Vial
Gross
$58,018
55292070254
$34,211
hemin 350 mg recon soln 1 each Vial
Gross
$57,018
55292070255
$34,211
hemin 350 mg recon soln 1 each Vial
Gross
$57,018
80203034701
$33,922
sutimlimab-jome 50 mg/mL solution 22 mL Vial
Gross
$56,537
51144005001
$33,836
brenTUXimab vedotin 50 mg recon soln 1 each Vial
Gross
$56,393
3232822
$33,377
ipilimumab 200 mg/40 mL (5 mg/mL) solution 40 mL Vial
Gross
$55,628
50242093301
$32,705
atezolizumab-hyaluronidase-tqjs 1875 mg-30000 unit/15 mL solution 15 mL Vial
Gross
$54,508
173089803
$32,297
dostarlimab-gxly 50 mg/mL solution 10 mL Vial
Gross
$53,829
50242091701
$31,752
atezolizumab 1200 mg/20 mL (60 mg/mL) solution 20 mL Vial
Gross
$52,921
169720501
$31,448
coagulation factor VIIA recomb per 1 mcg
Gross
$52,413
74501501
$31,403
risankizumab-rzaa 60 mg/mL solution 10 mL Vial
Gross
$52,338
73150015006
$31,353
ublituximab-xiiy 25 mg/mL solution 6 mL Vial
Gross
$52,255
68727074505
$30,537
daunorubicin per 1 mg/cytarabine per 2.27 mg
Gross
$50,895
68727074502
$30,537
daunorubicin per 1 mg/cytarabine per 2.27 mg
Gross
$50,895
50242010501
$30,455
polatuzumab vedotin-piiq 140 mg recon soln 1 each Vial
Gross
$50,759
50242092201
$29,037
emicizumab-kxwh 105 mg/0.7 mL solution 0.7 mL Vial
Gross
$48,395
3712511
$28,939
nivolumab-relatlimab-rmbw 240-80 mg/20 mL solution 20 mL Vial
Gross
$48,231
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 55566105000 | nadofaragene firadenovec-vncg 3x10exp11 vp/mL suspension 1 each Vial | $302,809 | $181,686 | — | — | 0 |
| 55566105001 | nadofaragene firadenovec-vncg 3x10exp11 vp/mL suspension 4 each Vial | $302,809 | $181,686 | — | — | 0 |
| 71336100101 | givosiran 189 mg/mL solution 1 mL Vial | $200,436 | $120,262 | — | — | 0 |
| 74106901 | risankizumab-rzaa 360 mg/2.4 mL (150 mg/mL) wearable injector 2.4 mL Cartridge | $143,107 | $85,864 | — | — | 0 |
| 74107001 | risankizumab-rzaa 360 mg/2.4 mL (150 mg/mL) wearable injector 2.4 mL Cartridge | $143,107 | $85,864 | — | — | 0 |
| 50242055401 | ocrelizumab-hyaluronidase-ocsq 920 mg-23000 unit/23 mL solution 23 mL Vial | $134,323 | $80,594 | — | — | 0 |
| 310453530 | tremelimumab-actl 20 mg/mL solution 15 mL Vial | $126,898 | $76,139 | — | — | 0 |
| 69488000301 | lutetium Lu 177 dotatate 10 mCi/mL (370 MBq/mL) solution 200 millicurie | $122,010 | $73,206 | — | — | 0 |
| 58468020001 | alemtuzumab 12 mg/1.2 mL solution 1.2 mL Vial | $121,497 | $72,898 | — | — | 0 |
| 96009029 | Pbb Inj, Adstiladrin, per Tx Dos | $121,374 | $72,824 | — | — | 0 |
| 30237890006 | sipuleucel-T-lactated ringers 50 million cell/250 mL suspension 250 mL Bag | $106,542 | $63,925 | — | — | 0 |
| 74725010064 | kit prep of Ga-68-gozetotide 25 mcg recon soln 50 millicurie Vial | $103,320 | $61,992 | — | — | 0 |
| 69488001061 | lutetium Lu-177 vipivotide tetraxetan 27 mCi/mL (1000 MBq/mL) solution 200 millicurie Vial | $99,356 | $59,613 | — | — | 0 |
| 78121761 | lutetium Lu-177 vipivotide tetraxetan 27 mCi/mL (1000 MBq/mL) solution 200 millicurie Vial | $99,356 | $59,613 | — | — | 0 |
| 57894006103 | ustekinumab 90 mg/mL syringe 1 mL Syringe | $95,861 | $57,516 | — | — | 0 |
| 50242015001 | ocrelizumab 30 mg/mL solution 10 mL Vial | $93,684 | $56,211 | — | — | 0 |
| 78073461 | canakinumab (PF) 150 mg/mL solution 1 mL Vial | $84,596 | $50,758 | — | — | 0 |
| 75987008010 | pegloticase 8 mg/mL solution 1 mL Vial | $84,436 | $50,662 | — | — | 0 |
| 73475310203 | efgartigimod-hyaluronidase-qvfc 1008 mg-11200 unit/5.6 mL solution 5.6 mL Vial | $78,702 | $47,221 | — | — | 0 |
| 72493010303 | mitoMYcin 40 mg x 2 kit 1 each KIT | $78,091 | $46,855 | — | — | 0 |
| 79952011001 | loncastuximab tesirine-lpyl 10 mg recon soln 1 each Vial | $77,343 | $46,406 | — | — | 0 |
| 75987013015 | teprotumumab-trbw 500 mg recon soln 1 each Vial | $77,198 | $46,319 | — | — | 0 |
| 25682002801 | ravulizumab-cwvz 100 mg/mL solution 11 mL Vial | $76,403 | $45,842 | — | — | 0 |
| 57894064001 | guselkumab 100 mg/mL syringe 1 mL Syringe | $69,956 | $41,974 | — | — | 0 |
| 57894065001 | guselkumab 200 mg/20 mL (10 mg/mL) solution 20 mL Vial | $69,221 | $41,533 | — | — | 0 |
| 57894065002 | guselkumab 200 mg/20 mL (10 mg/mL) solution 20 mL Vial | $69,221 | $41,533 | — | — | 0 |
| 24582411 | cabazitaxel 10 mg/mL (first dilution) solution 6 mL Vial | $69,203 | $41,522 | — | — | 0 |
| 72893000501 | PRALAtrexate 40 mg/2 mL (20 mg/mL) solution 2 mL Vial | $67,735 | $40,641 | — | — | 0 |
| 54482030101 | pegaspargase 750 unit/mL solution 5 mL Vial | $67,197 | $40,318 | — | — | 0 |
| 944381001 | pegaspargase 750 unit/mL solution 5 mL Vial | $67,197 | $40,318 | — | — | 0 |
| 80446040101 | tebentafusp-tebn 100 mcg/0.5 mL solution 0.5 mL Vial | $65,922 | $39,553 | — | — | 0 |
| 50242024501 | pertuzumab-trastuzumab-hy-zzxf 1200 mg-600mg- 30000 unit/15mL solution 15 mL Vial | $63,404 | $38,042 | — | — | 0 |
| 74347303 | leuprolide acetate (6 month) 45 mg syringe kit 1 each KIT | $62,025 | $37,215 | — | — | 0 |
| 59572077501 | luspatercept-aamt 50 mg/mL recon soln 1.5 mL Vial | $58,018 | $34,811 | — | — | 0 |
| 55292070254 | hemin 350 mg recon soln 1 each Vial | $57,018 | $34,211 | — | — | 0 |
| 55292070255 | hemin 350 mg recon soln 1 each Vial | $57,018 | $34,211 | — | — | 0 |
| 80203034701 | sutimlimab-jome 50 mg/mL solution 22 mL Vial | $56,537 | $33,922 | — | — | 0 |
| 51144005001 | brenTUXimab vedotin 50 mg recon soln 1 each Vial | $56,393 | $33,836 | — | — | 0 |
| 3232822 | ipilimumab 200 mg/40 mL (5 mg/mL) solution 40 mL Vial | $55,628 | $33,377 | — | — | 0 |
| 50242093301 | atezolizumab-hyaluronidase-tqjs 1875 mg-30000 unit/15 mL solution 15 mL Vial | $54,508 | $32,705 | — | — | 0 |
| 173089803 | dostarlimab-gxly 50 mg/mL solution 10 mL Vial | $53,829 | $32,297 | — | — | 0 |
| 50242091701 | atezolizumab 1200 mg/20 mL (60 mg/mL) solution 20 mL Vial | $52,921 | $31,752 | — | — | 0 |
| 169720501 | coagulation factor VIIA recomb per 1 mcg | $52,413 | $31,448 | — | — | 0 |
| 74501501 | risankizumab-rzaa 60 mg/mL solution 10 mL Vial | $52,338 | $31,403 | — | — | 0 |
| 73150015006 | ublituximab-xiiy 25 mg/mL solution 6 mL Vial | $52,255 | $31,353 | — | — | 0 |
| 68727074505 | daunorubicin per 1 mg/cytarabine per 2.27 mg | $50,895 | $30,537 | — | — | 0 |
| 68727074502 | daunorubicin per 1 mg/cytarabine per 2.27 mg | $50,895 | $30,537 | — | — | 0 |
| 50242010501 | polatuzumab vedotin-piiq 140 mg recon soln 1 each Vial | $50,759 | $30,455 | — | — | 0 |
| 50242092201 | emicizumab-kxwh 105 mg/0.7 mL solution 0.7 mL Vial | $48,395 | $29,037 | — | — | 0 |
| 3712511 | nivolumab-relatlimab-rmbw 240-80 mg/20 mL solution 20 mL Vial | $48,231 | $28,939 | — | — | 0 |
Showing top 50 of 23,144 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.